These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3374839)

  • 1. Effects of kainic acid lesions on calcium uptake and dopamine release in nerve endings isolated from rat striata.
    Drapeau P
    Neurosci Lett; 1988 Feb; 85(2):233-8. PubMed ID: 3374839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection.
    Bonanno G; Fedele E; Versace P; Raiteri M
    Brain Res; 1989 Feb; 480(1-2):242-8. PubMed ID: 2713653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of an intrastriatal injection of kainic acid on the dopaminergic neuronal and vesicular uptake systems.
    Naudon L; Leroux-Nicollet I; Costentin J
    Brain Res; 1992 Oct; 593(1):32-8. PubMed ID: 1360863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kainic acid-induced changes of serotonin and dopamine metabolism in the striatum and substantia nigra of the rat.
    Sperk G; Berger M; Hörtnagl H; Hornykiewicz O
    Eur J Pharmacol; 1981 Sep; 74(4):279-86. PubMed ID: 6170518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of endogenous level, uptake and release of taurine after intrastriatal kainic acid injection.
    Placheta P; Singer E; Schönbeck G; Heckl K; Karobath M
    Neuropharmacology; 1979 Apr; 18(4):399-402. PubMed ID: 450205
    [No Abstract]   [Full Text] [Related]  

  • 6. Release of biogenic amines from isolated nerve endings.
    Raiteri M; Bertollini A; del Carmine R; Levi G
    Adv Exp Med Biol; 1976; 69():319-35. PubMed ID: 941741
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in striatal cholinergic, gabaergic, dopaminergic and serotoninergic biochemical markers after kainic acid-induced thalamic lesions in the rat.
    Samuel D; Kerkerian-Le Goff L; Kumar U; Errami M; Scarfone E; Nieoullon A
    J Neural Transm Park Dis Dement Sect; 1990; 2(3):193-203. PubMed ID: 1979492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the metabolism and release of dopamine and amino acids from nerve endings isolated from sheep corpus striatum.
    De Belleroche JS; Bradford HF; Jones DG
    J Neurochem; 1976 Mar; 26(3):561-71. PubMed ID: 1262878
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of muscarinic receptors on striatal synaptosomes increases the release of endogenous dopamine.
    Bonanno G; Marchi M; Raiteri M
    Neuropharmacology; 1985 Mar; 24(3):261-4. PubMed ID: 3990922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of radiolabeled dopamine, serotonin, acetylcholine and GABA from slices of rat striatum after intrastriatal kainic acid injections.
    Frankhuyzen AL; Mulder AH
    Brain Res; 1977 Oct; 135(2):368-73. PubMed ID: 21721
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings.
    Sitges M; Nekrassov V; Guarneros A
    Brain Res; 2000 Jan; 854(1-2):48-56. PubMed ID: 10784106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential sensitivity of synaptosomal calcium entry and endogenous dopamine release to omega-conotoxin.
    Woodward JJ; Rezazadeh SM; Leslie SW
    Brain Res; 1988 Dec; 475(1):141-5. PubMed ID: 3214720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo electrochemical studies of the effects of N-methyl-D-aspartate (NMDA) on dopamine nerve terminals in the neostriatum of the anesthetized rat.
    Friedemann M; Gerhardt GA
    Proc West Pharmacol Soc; 1989; 32():143-7. PubMed ID: 2674955
    [No Abstract]   [Full Text] [Related]  

  • 14. Cocaine modulates allosteric D
    Beggiato S; Borelli AC; Borroto-Escuela D; Corbucci I; Tomasini MC; Marti M; Antonelli T; Tanganelli S; Fuxe K; Ferraro L
    Cell Signal; 2017 Dec; 40():116-124. PubMed ID: 28923416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
    Kelly E; Jenner P; Marsden CD
    J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrastriatal kainic acid elicits functional supersensitivity of muscarinic receptors regulating dopamine release.
    Versace P; Bocchieri P; Marchi M; Raiteri M
    Neurochem Int; 1987; 11(2):183-8. PubMed ID: 20501160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals.
    Krebs MO; Desce JM; Kemel ML; Gauchy C; Godeheu G; Cheramy A; Glowinski J
    J Neurochem; 1991 Jan; 56(1):81-5. PubMed ID: 1824785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric analysis and isolation of permeabilized dopamine nerve terminals from rat striatum.
    Wolf ME; Kapatos G
    J Neurosci; 1989 Jan; 9(1):106-14. PubMed ID: 2563275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of apomorphine in vitro on the uptake and release of catecholamines in crude synaptosomal preparations of rat striatum and hypothalamus.
    Ferris RM; Tang FL; Russell AV
    Biochem Pharmacol; 1975 Aug; 24(16):1523-7. PubMed ID: 1191310
    [No Abstract]   [Full Text] [Related]  

  • 20. Amino acids in rat neostriatum: alteration by kainic acid lesion.
    Nicklas WJ; Duvoisin RC; Berl S
    Brain Res; 1979 May; 167(1):107-17. PubMed ID: 455057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.